Literature DB >> 9531024

Factor VIII and von Willebrand factor.

A J Vlot1, S J Koppelman, B N Bouma, J J Sixma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9531024

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  9 in total

1.  6 Factor VIII Concentrates, Factor VIII/von Willebrand Factor Concentrates, Factor IX Concentrates, Activated Prothrombin Complex Concentrates.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 2.  Treatment of von Willebrand disease with FVIII/VWF concentrates.

Authors:  Giancarlo Castaman
Journal:  Blood Transfus       Date:  2011-05       Impact factor: 3.443

3.  Coagulation factor VIII levels are associated with long-term survival - interactions with gender in a large hospital-based cohort.

Authors:  Florian M Kovar; Claudia L Marsik; Christian Joukhadar; Thomas Perkmann; Helmuth Haslacher; Thomas Schickbauer; Paul A Kyrle; Oswald F Wagner; Georg Endler
Journal:  Wien Klin Wochenschr       Date:  2010-06-25       Impact factor: 1.704

4.  Pharmacological characteristics of solid-phase von Willebrand factor in human platelets.

Authors:  A Radomski; M W Stewart; P Jurasz; M W Radomski
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

5.  Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial.

Authors:  Pier Mannuccio Mannucci; Christine Kempton; Carolyn Millar; Edward Romond; Amy Shapiro; Ingvild Birschmann; Margaret V Ragni; Joan Cox Gill; Thynn Thynn Yee; Robert Klamroth; Wing-Yen Wong; Miranda Chapman; Werner Engl; Peter L Turecek; Tobias M Suiter; Bruce M Ewenstein
Journal:  Blood       Date:  2013-06-18       Impact factor: 22.113

6.  Platelet activation after presyncope by lower body negative pressure in humans.

Authors:  Morten Zaar; Chriselda G Fedyk; Heather F Pidcoke; Michael R Scherer; Kathy L Ryan; Caroline A Rickards; Carmen Hinojosa-Laborde; Victor A Convertino; Andrew P Cap
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

7.  The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complex.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  Biologics       Date:  2007-09

8.  Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications.

Authors:  Massimo Franchini; Franco Capra; Giovanni Targher; Martina Montagnana; Giuseppe Lippi
Journal:  Thromb J       Date:  2007-09-25

9.  Thrombin Generating Capacity and Phenotypic Association in ABO Blood Groups.

Authors:  Romy M W Kremers; Abdulrahman B O Mohamed; Leonie Pelkmans; Salwa Hindawi; H Coenraad Hemker; H Bas de Laat; Dana Huskens; Raed Al Dieri
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.